S
Suven Pharmaceuticals Ltd
Pharmaceuticals
MIDCAP
Pharmaceuticals
Live Performance vs
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 110.70 | 50.94 |
| PB Ratio | 16.21 | 6.51 |
| Dividend Yield | — | 0.52% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
About the company
S
Suven Pharmaceuticals Ltd
Suven Pharmaceuticals is engaged in Contract Research and Manufacturing Services (CRAMS), Drug Discovery & Development Support Services (DDDSS), Drug Discovery & Research/Clinical Pipeline, and Formulation Development
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions